To access this element change to forms mode OFF

Grant Award View - GA332285

Oral fenofibrate therapy to retard Chronic Kidney Disease in Type 2...

Contact Details

NHMRC Research Help Centre

:
1800500393

:

GA ID:
GA332285
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
8-May-2023
Publish Date:
22-Aug-2023
Category:
Medical Research
Grant Term:
1-Feb-2024 to 31-Jan-2029
Value (AUD):
$5,736,695.64 (GST inclusive where applicable)

One-off/Ad hoc:
No
Aggregate Grant Award:
No

PBS Program Name:
NHMRC 22/23 1.1 Health and Medical Research
Grant Program:
Clinical Trials and Cohort Studies
Grant Activity:
Oral fenofibrate therapy to retard Chronic Kidney Disease in Type 2 diabetes
Purpose:
Kidney disease is a major cause of illness and death in people with diabetes. A low-cost, well-tolerated drug, fenofibrate, appears to reduce kidney protein leak and protect kidneys from further damage.
This trial, enrolling patients across Australia, New Zealand and Asia (Malaysia, Hong Kong and Vietnam) aims to confirm our preliminary findings as to whether this treatment can delay late-stage kidney failure (which may require dialysis, kidney transplantation or cause death).

GO ID:
GO Title:
NHMRC Clinical Trials and Cohort Studies Grants 2022 for funding mid-2023
Internal Reference ID:
2023/GNT2024025
Selection Process:
Targeted or Restricted Competitive

Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property

Grant Recipient Details

Recipient Name:
University of Sydney
Recipient ABN:
15 211 513 464

Grant Recipient Location

Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA

Grant Delivery Location

State/Territory:
ACT, NSW
Postcode:
Multiple
Country:
AUSTRALIA

Contact Details

NHMRC Research Help Centre

:
1800500393

: